22157.jpg
CD40 Agonists & CD40/Ligand Antagonists Pipeline Market Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
October 24, 2024 10:14 ET | Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "CD40 Agonists & CD40/L Antagonists Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
Immunosuppressants Market
Immunosuppressants Research Report 2023-2024 & 2030: Healthcare Focus on Targeted, Patient-Centric Treatments Spurs Multi-Billion Dollar Growth Amid Rising Organ Transplants and Autoimmune Diseases
October 15, 2024 09:37 ET | Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Immunosuppressants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
22157.jpg
IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2024: Humanized, Fully Human, Chimeric, Other Sources Insights and Forecasts 2019-2023 & 2024-2029
September 23, 2024 07:07 ET | Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other...
22157.jpg
Etanercept Biosimilar Insight Market Report 2024: Pipeline Analysis, Therapeutic Assessment, Sales Assessment, Unmet Needs, and Impact of Drugs
September 19, 2024 10:21 ET | Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Etanercept - Biosimilar Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This "Etanercept - Biosimilar Insight, 2024" report...
22157.jpg
Cryopyrin-Associated Periodic Syndrome Drug Pipeline Report 2024: Therapeutic Developments for Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics, and Mabpharm
April 25, 2024 07:43 ET | Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Cryopyrin-Associated Periodic Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offeringThe global medical...
22157.jpg
US HUMIRA Market Projected for Extensive Growth by 2032 in Noninfectious Autoimmune Uveitis Sector
February 28, 2024 11:05 ET | Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "US HUMIRA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. An insightful analysis...
Global Axial Spondyloarthritis (Axspa) Market
Global Axial Spondyloarthritis (axSpA) Market Report 2023
January 30, 2024 20:24 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Axial Spondyloarthritis (axSpA) Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global axial...
22157.jpg
Global Rheumatoid Arthritis (RA) Drugs Research Report 2024: Market Set for Marginal Growth to 2028 - Long-term Forecasts to 2033
January 30, 2024 10:36 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global Rheumatoid Arthritis...
22157.jpg
Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Outlook 2024-2028: Product Innovations and Strategic Partnerships Catalyzing Industry Growth
January 23, 2024 11:48 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The tumor necrosis...
22157.jpg
Immunotherapy Advancements: CD40 Agonist and Antagonist Research Fuels Oncology and Autoimmunity Treatment Innovations
December 14, 2023 05:33 ET | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "CD40 Agonists & CD40/L Antagonists Pipeline Review" report has been added to ResearchAndMarkets.com's offering. The global scientific community...